1 active not recruiting, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Recruiting 1 |
Follow ISS: new trials by email Literature Review of ISS trials Research Report on ISS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature. Somatrogon, Genotropin - ISS, SGA | Phase 3 | Recruiting | Rabin Medical Center | 254 | 2026-02-01 | 2026-04-30 |
| A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9 Somapacitan - SGA, Turner Syndrome | Phase 3 | Active not recruiting | Novo Nordisk A/S | 47 | 2023-02-01 | 2026-08-13 |
Noonan Syndrome (1) · Turner Syndrome (1)
Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Chromosome Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Craniofacial Abnormalities (1) · Disorders of Sex Development (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Gonadal Disorders (1) · Gonadal Dysgenesis (1) · Heart Defects, Congenital (1)
Human Growth Hormone (1) · somapacitan (1) · somatrogon (1)
Novo Nordisk A/S (1) · Rabin Medical Center (1)
United States (2) · France (1) · India (1) · Israel (1) · Japan (1) · Malaysia (1) · Netherlands (1) · Poland (1) · South Korea (1) · Spain (1)